Table 4.

Outcome for patients with thyroid cancer enrolled on-study

Pt	Classification	Variant	Prior Radiotherapy, 131I Ablations	Time On Study (weeks)	Best Response	RAI Scan Obtained (weeks)a	Result
1	Papillary	Tall cell variant	RAI x2, EBb	10	PD	PD after cycle 3c	--
2	Papillary	Follicular variant	RAI x2, EB	12	PD	NDd	--
5	Papillary	Tall cell variant	RAI x3	112	SD	28, 53, 103	Neg
10	Papillary		RAI x2	39	SD	36	Faint
11	Papillary	Tall cell, poorly differentiated	EB only	3	PD	PD after cycle 1c	--
17	Follicular	Hürthle cell, poorly differentiated	RAI x1, EB	33	SD	31	Neg
18	Papillary	Tall cell, with Hashimoto’s thyroiditis	RAI x1, EB	33	SD	14, 30	Neg
24	Papillary		RAI x3	3	NE	Off Study after cycle 1e	--
26	Follicular	Hürthle cell	RAI x3	30	SD	16, 31	Neg
27	Follicular	Hürthle cell	RAI x3	27	SD	14	Faint
28	Papillary		RAI x3, EB	6	PD	PD after cycle 2c	--

^aTime when RAI scan obtained after study enrollment.

^bEB, External Beam radiotherapy also administered

^cRAI scans were not performed in patients with disease progression.

^dND, Not done. Patient with abdominal mass unable to tolerate low iodine diet.

^ePatient refused further therapy